Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin.
about
Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.Follicular Fluid redox involvement for ovarian follicle growthThe inositols and polycystic ovary syndromeThe "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).Ovarian Fibrosis: A Phenomenon of Concern.Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial.Is it time to consider patients suffering from endometriosis-related infertility as "novel candidates" for targeted peri-conceptional D-chiro inositol supplementation? Hypothesis, rationale and some considerations."Empiric" inositol supplementation in normal-weight non insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects.Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.Ameliorative effect of myo-inositol on red blood cell alterations in polycystic ovary syndrome: in vitro study.d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS.
P2860
Q33775146-37CB3E72-165E-4CE0-A64F-0672630CFA29Q33900945-8F0AB1A7-7089-4BA9-9AC1-509D07377523Q37292119-84CD28EE-EDD1-4CF8-8D9F-E1EDD3BE0AA5Q37502964-69D4E557-F7FE-4EA0-AEDE-A13D1B155BDCQ37640972-0DCB87D2-EAE6-436B-B6D3-9E8FCD366CDCQ38796542-FF1B49C3-DEC6-4087-B679-897E017BA005Q43190587-B202752B-76C8-4FC9-AF7F-21B4E897FE2DQ47405250-966204C4-A0F7-42C2-8852-C91AEA8AF83AQ47605793-2A2F5A6F-9DC8-4CBC-8093-079BF23D5519Q50075637-EB7B7DB5-4E5B-4FE8-90B6-E6517B1F5F84Q51304321-96EEA057-B470-4404-A51D-1E81BDD1C493
P2860
Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Protein modification as oxidat ...... ect of inositol and metformin.
@ast
Protein modification as oxidat ...... ect of inositol and metformin.
@en
Protein modification as oxidat ...... ect of inositol and metformin.
@nl
type
label
Protein modification as oxidat ...... ect of inositol and metformin.
@ast
Protein modification as oxidat ...... ect of inositol and metformin.
@en
Protein modification as oxidat ...... ect of inositol and metformin.
@nl
prefLabel
Protein modification as oxidat ...... ect of inositol and metformin.
@ast
Protein modification as oxidat ...... ect of inositol and metformin.
@en
Protein modification as oxidat ...... ect of inositol and metformin.
@nl
P2093
P2860
P50
P1476
Protein modification as oxidat ...... fect of inositol and metformin
@en
P2093
P2860
P2888
P304
P356
10.1007/S10815-014-0307-Z
P577
2014-08-12T00:00:00Z
P5875
P6179
1022939800